BOSTON, Feb. 21, 2017 -- Rapid7, Inc. (NASDAQ:RPD), a leading provider of security data and analytics solutions, today announced that management will present at the following investor conferences:
- The Morgan Stanley Technology, Media and Telecom Conference in San Francisco on February 27, 2017. The presentation is scheduled for 1:35 p.m. Pacific Time.
- The Raymond James 38th Annual Institutional Investors Conference in Orlando on March 8, 2017. The presentation is scheduled for 12:10 p.m. Eastern Time.
The presentations will be webcast live, and replays will be available for a limited time under the “Events and Presentations” section on the Company’s investor relations website at http://investors.rapid7.com.
About Rapid7
With Rapid7, technology professionals gain the clarity, command, and confidence to safely drive innovation and protect against risk. We make it simple to collect operational data across systems, eliminating blind spots and unlocking the information required to securely develop, operate, and manage today’s sophisticated applications and services. Our analytics and science transform your data into key insights so you can quickly predict, deter, detect, and remediate attacks and obstacles to productivity. Armed with Rapid7, technology professionals finally gain the insights needed to safely move their business forward. Rapid7 is trusted by more than 6,200 organizations across over 110 countries, including 38% of the Fortune 1000. To learn more about Rapid7 or get involved in our threat research, visit www.rapid7.com.
IR Contact: Jeff Bray Vice President, Investor Relations 857-415-4419 or [email protected]


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Instagram Outage Disrupts Thousands of U.S. Users
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 



